Alzheimer’s Research Program Transforming Diagnosis Award

The Fiscal Year 2025 Department of Defense Alzheimer’s Research Program (AZRP) outlines three primary award mechanisms aimed at advancing research related to Alzheimer’s disease and traumatic brain injury. Each mechanism targets independent investigators at varying career levels through single Principal Investigator (PI) options or partnering PI options, emphasizing community collaboration and specific guidelines for research methodologies. 1. **Transforming Diagnosis Award:** This award supports research to enhance diagnosis and prognosis of Alzheimer’s-related conditions in military personnel. The maximum funding is $1.5 million (or $1.7 million for Career Initiation or Transition investigators), with applications due by August 29, 2025, following a pre-proposal due on June 12, 2025. 2. **Transforming Research Award:** This mechanism funds studies aimed at reducing the risk or preventing Alzheimer’s development, particularly related to traumatic brain injury, with a budget cap of $1 million. Key requirements include the necessity for preliminary data and a focus on community collaboration, with similar deadlines as the Transforming Diagnosis Award. 3. **Transforming Care Award:** Focused on person-centered research, this award allows for clinical trials and requires a funding limit of $1.6 million (or $1.8 million for CIT), along with collaboration and preliminary data submission. All applications require initial pre-proposals submitted by June 12, 2025, before full applications due by August 29, 2025. This initiative illustrates the federal commitment to improving clinical approaches and outcomes for individuals affected by Alzheimer’s and related conditions.

The Department of Defense (DOD) is announcing the FY25 Alzheimer’s Research Program's Transforming Diagnosis Award, aimed at enhancing diagnosis and prognosis of Alzheimer’s disease and related dementias (AD/ADRD). With a funding pool of approximately $3.2 million, the program intends to support innovative research projects, allowing for applications under a single Principal Investigator (PI) or a Career Initiation or Transition Partnership Option. The funding caps are set at $1.5 million for single PI proposals and $1.7 million for partnered efforts, with a maximum performance period of four years. Eligible applicants include both extramural and intramural organizations, with specific requirements for PIs at various career stages. Community collaboration is mandated, ensuring projects reflect the needs of AD/ADRD communities. Submissions undergo a two-step application process — a pre-application followed by a full application for invited applicants, with the latter evaluated on criteria such as impact, research strategy, and progression plans. The award emphasizes addressing barriers to dementia diagnosis and prognosis with substantial preliminary data required. Projects cannot involve clinical trials or animal studies; instead, previous studies or patient data must form the basis for new research. This initiative represents a critical step in advancing the understanding and management of Alzheimer’s and related conditions, enhancing quality of life for affected individuals and their families.